Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease PURPOSE: To examine the safety, efficacy, costs, and impact on quality of life of ...
Early recurrence and outcome determinants in NF1-associated malignant peripheral nerve sheath tumors: A single-center retrospective analysis. This is an ASCO Meeting Abstract from the 2026 ASCO Annual ...
MIAMI, June 22, 2026 /PRNewswire/ -- PorTal Access, Inc., an innovative medical device company advancing vascular access technologies, today announced that the U.S. Food and Drug Administration (FDA) ...